nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Trial of Intrapatient Dose-Escalated Sorafenib in Patients With Metastatic Renal Cell Carcinoma
|
Amato, Robert |
|
2012 |
10 |
3 |
p. 153-158 6 p. |
artikel |
2 |
A Primary Signet Ring Cell Carcinoma of the Prostate With Bone Metastasis With Impressive Response to FOLFOX and Cetuximab
|
Roldán, Ana Milena |
|
2012 |
10 |
3 |
p. 199-201 3 p. |
artikel |
3 |
A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia
|
Serretta, Vincenzo |
|
2012 |
10 |
3 |
p. 174-179 6 p. |
artikel |
4 |
Cabazitaxel Rechallenge at Prostate-Specific Antigen Relapse After Previous Cabazitaxel and Docetaxel Chemotherapy: Case Report
|
Perry, Christina J. |
|
2012 |
10 |
3 |
p. 207-209 3 p. |
artikel |
5 |
Enduring Response to Everolimus as Third-Line Therapy in a Patient With Advanced Renal Cell Carcinoma, Including Small-Bowel Metastases: Loss of FHIT but Normal VHL Gene Status
|
Broom, Reuben J. |
|
2012 |
10 |
3 |
p. 202-206 5 p. |
artikel |
6 |
Metastatic Extraosseous Ewing's Sarcoma (EES)/Primitive Neuroectodermal Tumor (PNET) of the Kidney: 8-Year Durable Response After Induction and Maintenance Chemotherapy
|
Richey, Stephen L. |
|
2012 |
10 |
3 |
p. 210-212 3 p. |
artikel |
7 |
Neoadjuvant Hormone Therapy for Radical Prostate Radiotherapy: Bicalutamide Monotherapy vs. Luteinizing Hormone–Releasing Hormone Agonist Monotherapy: A Single-Institution Matched-Pair Analysis
|
McGivern, Ursula |
|
2012 |
10 |
3 |
p. 190-195 6 p. |
artikel |
8 |
Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt
|
Matei, Deliu-Victor |
|
2012 |
10 |
3 |
p. 164-173 10 p. |
artikel |
9 |
Neutrophil Number After Interferon-Alfa Treatment is an Independent Predictive Marker of Overall Survival in Metastatic Renal Cell Carcinoma
|
Azuma, Takeshi |
|
2012 |
10 |
3 |
p. 180-184 5 p. |
artikel |
10 |
Reappraisal of the Role of Bevacizumab in the Therapeutic Strategy in Advanced Renal Cell Carcinoma
|
Guillot, Aline |
|
2012 |
10 |
3 |
p. 147-152 6 p. |
artikel |
11 |
Spontaneous Regression of Thoracic Metastases While Progression of Brain Metastases After Stereotactic Radiosurgery and Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma: Abscopal Effect Prevented by the Blood-Brain Barrier?
|
Ishiyama, Hiromichi |
|
2012 |
10 |
3 |
p. 196-198 3 p. |
artikel |
12 |
The Role of IMiDs Alone or in Combination in Prostate Cancer
|
Nabhan, Chadi |
|
2012 |
10 |
3 |
p. 141-146 6 p. |
artikel |
13 |
Trends in the Use of Cytoreductive Nephrectomy in the United States
|
Tsao, Che-Kai |
|
2012 |
10 |
3 |
p. 159-163 5 p. |
artikel |
14 |
What is the Role of Enlarged Lymph Node Resection Alone in Patients With Nonseminomatous Germ Cell Tumor Who Had Stage II or III Disease?
|
Ekenel, Meltem |
|
2012 |
10 |
3 |
p. 185-189 5 p. |
artikel |